ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,370Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 3593

$1.74M Total Retail Price of All Prescriptions

Rank: 31 out of 3593

891 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 891 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 891 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 20,497 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 764 584 1 21
OMEPRAZOLE 744 571 2 5
LISINOPRIL 681 522 3 2
AMLODIPINE BESYLATE 551 453 4 3
LOSARTAN POTASSIUM 465 355 5 14
METOPROLOL TARTRATE 458 366 6 8
METFORMIN HCL 446 265 7 6
ATENOLOL 434 361 8 11
SIMVASTATIN 433 346 9 1
METOPROLOL SUCCINATE 425 388 10 19
LEVOTHYROXINE SODIUM 422 381 11 4
FUROSEMIDE 377 302 12 9
ATORVASTATIN CALCIUM 361 308 13 15
ADVAIR DISKUS 334 181 14 47
CARVEDILOL 325 278 15 23
DIOVAN 321 265 16 46
CLOPIDOGREL 319 266 17 30
HYDROCHLOROTHIAZIDE 318 214 18 10
PANTOPRAZOLE SODIUM 299 245 19 45
PRAVASTATIN SODIUM 296 240 20 13
GABAPENTIN 285 202 21 16
PROAIR HFA 254 118 22 54
ZOLPIDEM TARTRATE 251 194 23 12
ENALAPRIL MALEATE 251 215 23 38
TAMSULOSIN HCL 250 213 25 33
PLAVIX 249 221 26 42
ALPRAZOLAM 249 245 26 37
TRAMADOL HCL 248 136 28 17
FAMOTIDINE 245 150 29 70
IBUPROFEN 236 133 30 43
RANITIDINE HCL 230 176 31 27
NEXIUM 221 130 32 36
CITALOPRAM HBR 216 176 33 25
DONEPEZIL HCL 202 191 34 31
LORAZEPAM 185 172 35 98
WARFARIN SODIUM 176 136 36 18
TEMAZEPAM 176 164 36 56
METFORMIN HCL ER 170 152 38 67
SPIRONOLACTONE 160 135 39 86
FINASTERIDE 160 146 39 79
NAMENDA 151 150 41 50
FLUTICASONE PROPIONATE 148 89 42 32
SINGULAIR 144 64 43 77
EXELON 139 117 44 123
TRAZODONE HCL 135 79 45 53
LANTUS 134 88 46 57
HYDROCODONE-ACETAMINOPHEN 133 113 S3 47 7
LOSARTAN-HYDROCHLOROTHIAZIDE 128 128 48 48
TRICOR 127 86 49 130
PREDNISONE 126 81 50 49
AZITHROMYCIN 126 106 50 34
LYRICA 124 103 52 105
SPIRIVA 124 67 52 87
PROPRANOLOL HCL 123 77 54 181
HYDRALAZINE HCL 120 116 55 107
DOXAZOSIN MESYLATE 119 117 56 63
CYMBALTA 118 98 57 73
CLONIDINE HCL 117 73 58 41
QUETIAPINE FUMARATE 113 96 59 89
FENOFIBRATE 111 98 60 39
ALLOPURINOL 110 105 61 35
GLIPIZIDE 110 97 61 40
MUPIROCIN 110 76 61 132
TOPIRAMATE 109 38 64 306
MIRTAZAPINE 108 95 65 64
CLOTRIMAZOLE-BETAMETHASONE 106 80 66 94
LEVETIRACETAM 106 59 66 127
PAROXETINE HCL 103 81 68 62
MELOXICAM 103 103 68 29
DIGOXIN 102 90 70 58
LIDODERM 101 83 71 78
NAPROXEN 101 80 71 68
DIOVAN HCT 101 87 71 76
ISOSORBIDE MONONITRATE ER 100 86 74 61
ONGLYZA 99 42 75 221
BENICAR 97 85 76 131
RISPERIDONE 93 65 77 83
ESCITALOPRAM OXALATE 93 78 77 71
TRIAMCINOLONE ACETONIDE 90 82 79 119
LANSOPRAZOLE 90 85 79 113
DICLOFENAC SODIUM 89 77 81 74
LOVAZA 89 61 81 106
MONTELUKAST SODIUM 87 40 83 151
NOVOLOG 87 70 83 134
SYNTHROID 87 81 83 51
SERTRALINE HCL 86 78 86 28
CELEBREX 83 65 87 100
AGGRENOX 82 59 88 288
LACTULOSE 79 54 89 126
PRANDIN 78 58 90 317
HYDROCORTISONE 78 63 90 273
AMMONIUM LACTATE 78 37 90 125
LATANOPROST 78 68 90 195
ZETIA 77 67 94 110
PHENYTOIN SODIUM EXTENDED 72 31 95 165
BENZTROPINE MESYLATE 71 31 R 96 202
POTASSIUM CHLORIDE 70 65 97 24
VENTOLIN HFA 70 42 97 80
GLYBURIDE-METFORMIN HCL 70 67 R 97 95
ACTOS 69 55 100 133
ALENDRONATE SODIUM 69 69 100 22
VERAPAMIL ER 68 68 102 99
JANUVIA 68 48 102 81
CLONAZEPAM 66 61 104 164
AMIODARONE HCL 66 66 104 269
LUMIGAN 65 53 106 333
AMOX TR-POTASSIUM CLAVULANATE 64 55 107 138
AMITRIPTYLINE HCL 63 43 R 108 90
MEGESTROL ACETATE 63 62 R 108 152
VIAGRA 62 48 110 84
CIPROFLOXACIN HCL 59 54 111 52
MECLIZINE HCL 58 54 112 96
GENERLAC 58 55 112 271
LOVASTATIN 58 58 112 20
HYDROXYZINE HCL 58 41 R 112 196
NOVOLIN R 58 52 112 140
DOXEPIN HCL 56 49 117 284
CREON 56 54 117 462
TRIAMTERENE-HCTZ 56 53 117 66
VOLTAREN 56 42 117 85
IBANDRONATE SODIUM 55 44 121 253
LANTUS SOLOSTAR 55 26 121 122
KLOR-CON 10 54 46 123 114
RAMIPRIL 52 27 124 92
KETOCONAZOLE 51 39 125 118
GLIMEPIRIDE 51 35 125 44
ACETAMINOPHEN-CODEINE 50 40 S3 127 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.